Corticosteroids Treatment of Patients with Coronavirus Disease 2019: A Propensity Score Matching Study

Link to article at PubMed

Curr Med Sci. 2021 Feb;41(1):24-30. doi: 10.1007/s11596-021-2313-6. Epub 2021 Feb 13.


The role of corticosteroids in the treatment of Coronavirus disease 2019 (COVID-19) is controversial. In the present study, we evaluated the effects of adjuvant corticosteroids treatment on the outcome of patients with COVID-19 (n=966), using Propensity Score Matching to adjust for potential differences between the corticosteroids group (n=289) and the non-corticosteroids group (n=677). Analysis of data without adjusting differences in baseline characteristics indicated that the proportion of mechanical ventilation and the mortality was higher in the corticosteroids treatment group in total or severe/critical patients. The duration of viral shedding was longer in the non-corticosteroids treatment group in total or general/mild patients. After adjusting the difference between the corticosteroids and non-corticosteroids treatment group, the analysis revealed that the use of corticosteroids had no effect on the duration of viral shedding, in-hospital mortality or 28-day mortality.

PMID:33582901 | DOI:10.1007/s11596-021-2313-6

Leave a Reply

Your email address will not be published. Required fields are marked *